Announce Date | 05/05/2025 |
EPS Normalized Actual | $0.13 In Line |
EPS GAAP Actual | $0.13 In Line |
Revenue Actual | $0.883855B |
Revenue Surprise | Beat by $883.855M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.096638 |
EPS GAAP Estimate | $0.096638 |
Revenue Estimate | $0.78399379B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0.52 | 251.32 | 0.48057 | 0.58067 | 1 |
Dec 2026 | 0.36894 | 354.22 | 0.3 | 0.46575 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.09 | -0.004526 | 0.883855B | 28.23% | 132.13M |
FQ4 2024 (Dec 2024) | 0.0343 | 0.0343 | 0.827519B | 26.49% | 827.52M |
FQ3 2024 (Sep 2024) | 0.0643 | 0.0643 | 0.725516B | 23.07% | 725.52M |
FQ2 2024 (Jun 2024) | 0.0601 | 0.0601 | 0.678134B | 21.36% | 678.13M |
FQ1 2024 (Mar 2024) | 0.0477 | 0.0477 | 0.634338B | 17.21% | 634.34M |
FQ1 2019 (Mar 2019) | -0.25 | -0.25 | 0.161328B | 100% | 161.33M |
FQ2 2019 (Jun 2019) | -0.23 | -0.23 | 0.17632B | 100% | 176.32M |
FQ4 2023 (Dec 2023) | 0.0427 | 0.0427 | 0.60835B | 100% | 608.35M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.096638
Consensus Revenue Estimates
0.78399379B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.21682 | -- | 0.21228 | 0.2229 | 8 |
FQ2 2027 (Jun 2027) | 0.21263 | -- | 0.20818 | 0.21859 | 8 |
FQ1 2027 (Mar 2027) | 0.19837 | -- | 0.19422 | 0.20393 | 9 |
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 3 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 3 |
FQ2 2026 (Jun 2026) | 0.15 | -- | 0.14586 | 0.16058 | 3 |
FQ1 2026 (Mar 2026) | 0.14 | 35.71 | 0.13614 | 0.14988 | 5 |
FQ4 2025 (Oct 2025) | 0.099588 | 65.56 | 0.09576245 | 0.11167 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.47B | -- | 1.44B | 1.5B | 14 |
FQ2 2027 (Jun 2027) | 1.42B | -- | 1.4B | 1.45B | 9 |
FQ1 2027 (Mar 2027) | 1.34B | -- | 1.31B | 1.36B | 9 |
FQ4 2026 (Oct 2026) | 0.87B | -- | 0.84B | 0.95B | 4 |
FQ3 2026 (Jul 2026) | 0.85B | -- | 0.82B | 0.92B | 4 |
FQ2 2026 (Jun 2026) | 0.92B | -- | 0.9B | 0.97B | 5 |
FQ1 2026 (Mar 2026) | 0.91B | 2.4 | 0.89B | 0.95B | 4 |
FQ4 2025 (Oct 2025) | 0.82B | -1.2 | 0.79B | 0.89B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.094526 | 0.09 | -0.004526 | -5.03% |
FQ4 2024 (Dec 2024) | 0.0343 | 0.0343 | 100% | |
FQ3 2024 (Sep 2024) | 0.0643 | 0.0643 | 100% | |
FQ2 2024 (Jun 2024) | 0.0601 | 0.0601 | 100% | |
FQ1 2024 (Mar 2024) | 0.0477 | 0.0477 | 100% | |
FQ1 2019 (Mar 2019) | -0.25 | -0.25 | 100% | |
FQ2 2019 (Jun 2019) | -0.23 | -0.23 | 100% | |
FQ4 2023 (Dec 2023) | 0.0427 | 0.0427 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.75B | $0.88B | $132.13M | 14.95% |
FQ4 2024 (Dec 2024) | $0B | $0.83B | $827.52M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.73B | $725.52M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.68B | $678.13M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.63B | $634.34M | 100% |
FQ1 2019 (Mar 2019) | $0B | $0.16B | $161.33M | 100% |
FQ2 2019 (Jun 2019) | $0B | $0.18B | $176.32M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.61B | $608.35M | 100% |